Correction: Lipolysis-stimulated lipoprotein receptor overexpression is a novel predictor of poor clinical prognosis and a potential therapeutic target in gastric cancer
Oncotarget
.
2021 Oct 12;12(21):2232-2233.
doi: 10.18632/oncotarget.28096.
Authors
Takahito Sugase
1
2
3
,
Tsuyoshi Takahashi
1
,
Satoshi Serada
2
,
Minoru Fujimoto
2
,
Tomoharu Ohkawara
2
,
Kosuke Hiramatsu
1
2
3
,
Masahiro Koh
1
,
Yurina Saito
1
,
Koji Tanaka
1
,
Yasuhiro Miyazaki
1
,
Tomoki Makino
1
,
Yukinori Kurokawa
1
,
Makoto Yamasaki
1
,
Kiyokazu Nakajima
1
,
Kazuhiro Hanazaki
3
,
Masaki Mori
1
,
Yuichiro Doki
1
,
Tetsuji Naka
2
Affiliations
1
Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita, Japan.
2
Center for Intractable Immune Disease, Kochi University, Nankoku, Japan.
3
Department of Surgery, Kochi University, Nankoku, Japan.
PMID:
34676057
PMCID:
PMC8522840
DOI:
10.18632/oncotarget.28096
Abstract
[This corrects the article DOI: 10.18632/oncotarget.25952.].
Copyright: © 2021 Sugase et al.
Publication types
Published Erratum